Goldman Sachs
ONCR

Goldman Sachs’s Oncorus, Inc. ONCR Stock Holding History

Goldman Sachs’s Portfolio ONCR Stock Details ONCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10,195
Closed -$3.51K – 6220
2023
Q1 		$3.51K Sell
10,195
-6,994
-41% -$2.61K ﹤0.01% 5826
2022
Q4 		$4.35K Sell
17,189
-7,222
-30% -$4.11K ﹤0.01% 5823
2022
Q3 		$21K Sell
24,411
-93,514
-79% -$120K ﹤0.01% 5932
2022
Q2 		$148K Buy
117,925
+30,668
+35% +$41.7K ﹤0.01% 5740
2022
Q1 		$155K Sell
87,257
-20,429
-19% -$57.2K ﹤0.01% 5970
2021
Q4 		$568K Buy
107,686
+30,075
+39% +$233K ﹤0.01% 5289
2021
Q3 		$725K Sell
77,611
-89,437
-54% -$1.02M ﹤0.01% 4974
2021
Q2 		$2.31M Buy
167,048
+79,097
+90% +$1.22M ﹤0.01% 4076
2021
Q1 		$1.22M Buy
87,951
+73,434
+506% +$1.52M ﹤0.01% 4447
2020
Q4 		$469K Buy
+14,517
New +$336K ﹤0.01% 4643

Other funds holding ONCR

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
YAL
Your Advocates Ltd Houston, Texas $328M AUM 19.81% 1-Year Est. Return